— Research & Development
Oncology Pipeline
We continue to build our treatment portfolio with a current focus on oncology within the United States.
Learn More— Join Our Team
See a Future at Servier?
Learn more about working at Servier and search our current job openings to see if there is a career opportunity for you.
Learn More
Latest News

Through the acquisition of Agios Pharmaceuticals #oncology #business, we are proud to strengthen our portfolio in malignant hematology and solid tumors and expand our presence in the U.S.
Learn More
Our CEO, David K. Lee, recently spoke with Luke Timmerman on his podcast, The Long Run, discussing how his upbringing influenced his desire to impact patient's lives directly, and how Servier is a different kind of pharmaceutical company.
Learn More
Servier Completes Acquisition of Agios Pharmaceuticals' Oncology Business
Learn MoreAdobe Stock©Mat Hayward | Adobe Stock©REDPIXEL | Adobe Stock©Gorodenkoff | Adobe Stock©Monkey Business